Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in ...
Teva Pharmaceutical ( (TEVA)) has provided an update. Teva Pharmaceutical Industries has appointed Chen Lichtenstein as a new independent Board member, effective December 1, 2024. With a robust ...
Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit ...
The major indices have turned red at midday. The yield on the 10-year Treasury note is down 3 bps at 4.43%. Oil is up 1% at $69 per barrel. Bitcoin is down 5% at $88,000. Wholesale inflation numbers ...
The Associated Press on MSN14d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drugThe European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...
Teva Pharmaceutical (TEVA) stock gains in premarket after the company posted better than expected Q3 2024 financials and ...
Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...
UPI News on MSN14d
Drugmaker Teva Pharmaceuticals fined $500M by European regulatorsTeva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback